Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 5, Pages 1011
Publisher
MDPI AG
Online
2021-03-01
DOI
10.3390/cancers13051011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemotherapy-associated steatohepatitis
- (2020) Lucy Meunier et al. Annals of Hepatology
- BIOMEX: an interactive workflow for (single cell) omics data interpretation and visualization
- (2020) Federico Taverna et al. NUCLEIC ACIDS RESEARCH
- Targeted Therapies in Advanced Gastric Cancer
- (2020) Timil H. Patel et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases
- (2020) Masayuki Fujii et al. NATURE MATERIALS
- Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review
- (2019) Yuanda Liu et al. OncoTargets and Therapy
- B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2
- (2019) Tongguo Shi et al. Cell Death & Disease
- Tumor organoids: From inception to future in cancer research
- (2019) Liang Yang et al. CANCER LETTERS
- Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer
- (2019) Ji‐Hye Park et al. CANCER SCIENCE
- Adjuvant chemotherapy in resected colon cancer: When, how and how long?
- (2019) Alain J. Gelibter et al. SURGICAL ONCOLOGY-OXFORD
- Glucose Metabolism in Pancreatic Cancer
- (2019) Liang Yan et al. Cancers
- Organoids: the new kid in cancer research
- (2019) Vignesh Narasimhan et al. ANZ JOURNAL OF SURGERY
- CoA Synthase (COASY) mediates radiation resistance via PI3K signaling in rectal cancer
- (2019) Sylvain Ferrandon et al. CANCER RESEARCH
- Enhancer of Zeste Homolog 2 in Colorectal Cancer Development and Progression
- (2019) Sebastian C.B. Bremer et al. DIGESTION
- PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells
- (2019) Siyuan Yan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Colorectal cancer
- (2019) Evelien Dekker et al. LANCET
- Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway
- (2019) Yu Liang et al. ONCOGENE
- Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients
- (2019) Ilya G. Serebriiskii et al. Nature Communications
- Crucial players in glycolysis: Cancer progress
- (2019) Zaka Abbaszadeh et al. GENE
- Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner
- (2019) Reika Shiratori et al. Scientific Reports
- PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis
- (2018) Fang Peng et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Endothelial Cell Metabolism in Health and Disease
- (2018) Katerina Rohlenova et al. TRENDS IN CELL BIOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer
- (2018) Stephan Paschke et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- How cerebral organoids are guiding brain-cancer research and therapies
- (2018) Anna Nowogrodzki NATURE
- Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations
- (2018) Rekha Pal et al. PLoS One
- Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination
- (2018) Nina M. S. Gustafsson et al. Nature Communications
- The ERK and JNK pathways in the regulation of metabolic reprogramming
- (2018) Salvatore Papa et al. ONCOGENE
- Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine
- (2018) Adam Paulík et al. TUMORI
- Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC
- (2017) Kiyotoshi Satoh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells
- (2017) Ilaria Elia et al. Nature Communications
- Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis
- (2017) Jiayuan Wu et al. Oncotarget
- Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy
- (2016) Anna Rita Cantelmo et al. CANCER CELL
- Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
- (2016) Laura Pisarsky et al. Cell Reports
- Active and water-soluble form of lipidated Wnt protein is maintained by a serum glycoprotein afamin/α-albumin
- (2016) Emiko Mihara et al. eLife
- PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer
- (2016) Wei Zhu et al. PLoS One
- Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies
- (2016) Peter Jo et al. Scientific Reports
- Interleukin-6 stimulates aerobic glycolysis by regulating PFKFB3 at early stage of colorectal cancer
- (2015) JUN HAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
- (2015) Antonio Colaprico et al. NUCLEIC ACIDS RESEARCH
- miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells
- (2015) JING-YU DU et al. ONCOLOGY REPORTS
- Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
- (2015) Katarzyna Tomczak et al. Wspolczesna Onkologia-Contemporary Oncology
- A Fresh View of Glycolysis and Glucokinase Regulation: History and Current Status
- (2014) Sigurd Lenzen JOURNAL OF BIOLOGICAL CHEMISTRY
- Meta-analysis of immunohistochemical expression of hypoxia inducible factor-1α as a prognostic role in gastric cancer
- (2014) Shuang Lin WORLD JOURNAL OF GASTROENTEROLOGY
- 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27
- (2014) A Yalcin et al. Cell Death & Disease
- Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy
- (2014) T Grabinger et al. Cell Death & Disease
- Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
- (2013) Katrien De Bock et al. CELL
- Epigenetic and genetic features of 24 colon cancer cell lines
- (2013) D Ahmed et al. Oncogenesis
- Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker
- (2012) Meike Schneider et al. BMC CANCER
- Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
- (2012) JIE ZHENG Oncology Letters
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Glycolysis inhibition by 2-deoxy-d-glucose reverts the metastatic phenotype in vitro and in vivo
- (2011) Joseph L. Sottnik et al. CLINICAL & EXPERIMENTAL METASTASIS
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
- (2011) Toshiro Sato et al. GASTROENTEROLOGY
- Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers
- (2011) Hiromichi Ebi et al. JOURNAL OF CLINICAL INVESTIGATION
- HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers
- (2010) Yoshifumi Baba et al. AMERICAN JOURNAL OF PATHOLOGY
- Principles of early drug discovery
- (2010) JP Hughes et al. BRITISH JOURNAL OF PHARMACOLOGY
- Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma
- (2010) Fernanda Rocha Rojas Ayala et al. MOLECULES
- A scaling normalization method for differential expression analysis of RNA-seq data
- (2010) Mark D Robinson et al. GENOME BIOLOGY
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Effect of Rising Chemotherapy Costs on the Cost Savings of Colorectal Cancer Screening
- (2009) Iris Lansdorp-Vogelaar et al. JNCI-Journal of the National Cancer Institute
- Consensus transcriptome signature of perineural invasion in pancreatic carcinoma
- (2009) I. Abiatari et al. MOLECULAR CANCER THERAPEUTICS
- Target specificity and off-target effects as determinants of cancer drug efficacy
- (2008) Maria C Shoshan et al. Expert Opinion on Drug Metabolism & Toxicology
- The role of earlyin vivotoxicity testing in drug discovery toxicology
- (2008) Mark R Fielden et al. Expert Opinion On Drug Safety
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now